会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Fatty acid esters of 8-substituted
10-[4-(hydroxyalkyl)piperazino]-10,11-dihydrodibenzo[b,f]thiepins
    • 8-取代的10- {8 4-(羟基烷基)哌嗪基{9-10,11-二氢二苯并{8b,f {9 thiepins)的脂肪酸酯
    • US3985750A
    • 1976-10-12
    • US490218
    • 1974-07-19
    • Miroslav ProtivaJiri JilekKarel SindelarJirina Metysova
    • Miroslav ProtivaJiri JilekKarel SindelarJirina Metysova
    • C07D313/12C07D337/14C07D409/04
    • C07D337/14C07D313/12
    • Fatty acid esters of 8-substituted 10-[4-(hydroxyalkyl)piperazino]-10,11-dihydrodibenzo[b,f]thiepins and oxepins having the formula ##SPC1##In which X is a sulfur or oxygen atom, R.sup.1 is a hydrogen, chloro, or trifluoromethyl radical, a lower alkyl radical having at most 5 carbon atoms, or a cycloalkyl radical having at least 3 and at most 8 carbon atoms, or an alkoxy or alkylthio radical the alkyl moiety of which has at most 4 carbon atoms, R.sup.2 is an alkyl radical having at least 5 and at most 17 carbon atoms, and n is 2, 3, or 4, and their salts with pharmaceutically acceptable inorganic and organic acids. The compounds have a high degree of neuroleptic activity and retain this activity for long periods after administration.Related fatty acid esters of 8-substituted 10-[4-(hydroxyalkyl)-piperazino]dibenzo[b,f]thiepins and oxepins having the formula ##SPC2##And fatty acid esters of 8-substituted 4-[4-(hydroxyalkyl)piperazino]thieno[2,3-b]-1-benzothiepins and oxepins having the formula ##SPC3##In which formulae X, R.sup.1, R.sup.2 and n each have the foregoing significance, are also included herein.
    • 8-取代的10- [4-(羟基烷基)哌嗪基] -10,11-二氢二苯并[b,f]硫蛋白和具有式IN的氧杂环丁烷的脂肪酸酯,其中X是硫或氧原子,R1是氢,氯 或三氟甲基,具有至多5个碳原子的低级烷基或具有至少3个且至多8个碳原子的环烷基,或其烷基部分具有至多4个碳原子的烷氧基或烷硫基,R 2 是具有至少5个且至多17个碳原子,n为2,3或4的烷基,以及它们与药学上可接受的无机酸和有机酸的盐。 这些化合物具有高度的精神安定性活性,并且在施用后长时间保留该活性。
    • 10. 发明授权
    • Heterocyclic compounds
    • 杂环化合物
    • US06214816B1
    • 2001-04-10
    • US09266236
    • 1999-03-10
    • Rolf HohlwegTine Krogh JørgensenKnud Erik AndersenUffe Bang OlsenZdenék PolivkaKarel Sindelar
    • Rolf HohlwegTine Krogh JørgensenKnud Erik AndersenUffe Bang OlsenZdenék PolivkaKarel Sindelar
    • C07D40106
    • C07D403/06C07D413/06
    • The compounds are N-substituted azaheterocyclic compounds of formula I wherein R1 and R2 independently are hydrogen, halogen, trifluoromethyl, hydroxy, C1-6-alkyl or C1-6-alkoxy; and Y is >N—CH2— wherein only the underscored atom participates in the ring system; and X is —C(R6R7)—, —CH2CH2—, —CH═CH—CH2—, —CH2—CH═CH—, —CH2—(C═O)—, —(C═O)—CH2—, —CH2CH2CH2—, —CH═CH—, CH(R10)CH2—, —CH2CH(R10) or —(C═O)— wherein R6 and R7 independently are hydrogen or C1-6-alkyl and wherein R10 is C1-6-alkyl or phenyl; and r is 0, 1 or 2; and Z is selected from wherein A is —CH2—, —O—, —S— or —N(R5)— wherein R5 is H or C1-6-alkyl; and R3 is —(CH2)pCOR4 wherein p is 1, 2, 3 or 4 and R4 is OH, NH2, NHOH or C1-6-alkoxy; or a pharmaceutically acceptable salt thereof. These compounds are useful for treating painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation. They are also useful for treating indications caused by or related to the secretion and circulation of insulin antagonizing peptides, e.g., non-insulin-dependent diabetes mellitus (NIDDM) and ageing-associated obesity.
    • 化合物是式I的N-取代的氮杂环化合物,其中R1和R2独立地是氢,卤素,三氟甲基,羟基,C1-6烷基或C1-6-烷氧基; 并且Y是> N-CH 2 - ,其中只有下划线原子参与环系; 并且X是-C(R 6 R 7) - , - CH 2 CH 2 - , - CH = CH-CH 2 - , - CH 2 -CH = CH-, - CH 2 - (C = O) - , - (C = O) -CH 2 CH 2 CH 2 - , - CH = CH-,CH(R 10)CH 2 - , - CH 2 CH(R 10)或 - (C = O) - 其中R 6和R 7独立地是氢或C 1-6 - 烷基,其中R 10是C 1-6 - 烷基或苯基; 和r为0,1或2; 并且Z选自其中A是-CH 2 - , - O - , - S-或-N(R 5) - ,其中R 5是H或C 1-6 - 烷基; 并且R 3是 - (CH 2)p COR 4,其中p是1,2,3或4,并且R 4是OH,NH 2,NHOH或C 1-6 - 烷氧基; 或其药学上可接受的盐。 这些化合物可用于治疗C型纤维通过引起神经源性疼痛或炎症而发挥病理生理学作用的疼痛,痛觉过敏和/或炎性病症。 它们还可用于治疗由胰岛素拮抗肽(例如非胰岛素依赖性糖尿病(NIDDM))和老龄化相关性肥胖症分泌和循环引起或与之相关的适应症。